Publication | Open Access
Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate
19
Citations
9
References
2022
Year
MedicineImmunologyImmune SurveillanceAntibody EngineeringImmunotherapyPharmacologyNovel TherapyStro-002 Folr1–antibody-drug Conjugate
| Year | Citations | |
|---|---|---|
Page 1
Page 1